News
What is new in adipocyte biology this week. Primary literature first, noise last.
Editorial framing beige and brown adipocyte plasticity as a live therapeutic target for metabolic disease, not just a curiosity.
Review of adipose browning tied to disease states, not only cold exposure or exercise.
Depot location (visceral vs subcutaneous vs others) changes adipocyte function and disease risk, not just fat mass.
snRNA-seq of subcutaneous and visceral depots from human subjects with varying metabolic disease severity; progenitor cell populations outperform mature adipocyte counts as disease markers.
The thermogenic compartment of white adipose tissue is not uniform; UCP1-expressing and futile-cycling subtypes have distinct gene programs and likely distinct therapeutic relevance.
Cellular composition, inflammatory status, and developmental origin of a depot predict disease better than body mass index alone across multiple conditions.
2025 review synthesizing how stressed adipocyte mitochondria, ER stress, and altered adipokine secretion together drive metabolic disease.
snRNA-seq of subcutaneous adipose from 84 subjects with metabolic syndrome shows WNT pathway activity in progenitor cells shapes downstream adipocyte maturation.
Adipocyte-intrinsic mechanisms of GLP-1RA resistance are not yet characterized; this review flags the clinical pattern and asks what the fat cell is doing differently.
Editorial collecting pharmacologic approaches aimed at adipose tissue itself, not just energy balance or appetite, as the treatment target.
A peroxisomal pathway involving monomethyl branched-chain fatty acid metabolism drives thermogenesis in fat cells without UCP1; opens a new target class for non-UCP1 browning.